StockWatch
·
Pharmaceuticals
Board Meeting30 Oct 2026, 05:10 pm

Span Divergent Ltd Board Meeting on Nov 5 to Approve Q2 FY27 Results

AI Summary

Span Divergent Ltd has announced a Board of Directors meeting scheduled for November 5, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Concurrently, the company will implement a trading window closure for its designated persons, effective until 48 hours after the financial results are declared, in compliance with SEBI's insider trading regulations.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • To approve unaudited standalone and consolidated financial results.
  • Results pertain to the quarter and half-year ended September 30, 2026.
  • Trading window to remain closed for designated persons.
  • Closure is in line with SEBI's insider trading regulations.